Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px
Document › Details

Bayer AG. (7/17/24). "Press Release: Darolutamide Meets Primary Endpoint in Phase III ARANOTE Trial in Men with Metastatic Hormone-sensitive Prostate Cancer [Not intended for U.S. and UK Media]". Berlin.

Organisation Organisation Bayer Pharma AG
  Group Bayer (Group)
Products Product Nubeqa®
  Product 2 phase 3 study
Person Person Rommel, Christian (Bayer 202102– Head RnD of Pharma division before Roche + Amgen + Intellikine + Merck Serono)
     


   
Record changed: 2024-09-11

Advertisement

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x300px




» top